ChromoGenics receives order from Korea for evaluation of ConverLight

ChromoGenics AB (publ) has signed a commercial order of approximately SEK 200 thousand with a company in Korea in order to evaluate ConverLight® for the Korean market. The intention is to see how the product meets the Korean requirements and to evaluate the forms of possible cooperation between the companies.

The agreement is evidence of great interest in our technology ConverLight around the world. The test delivery relates to an evaluation of ConverLight in order to eventually expand the Korean company’s product portfolio with an electrochromic solar control product and is in line with ChromoGenic’s long-term strategy of building worldwide partnerships.

“It is great that our discussions with potential partners begin to gain momentum and that international companies show interest in our technology. We are pleased to be able to deliver our product for testing and evaluation for new market areas. ChromoGenic’s long term strategy is to expand by delivering electrochromic ConverLight foil to hubs around the world and we consider these test projects as the first steps to future expansions,” says Jerker Lundgren, CEO of ChromoGenics.


Jerker Lundgren, CEO
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 

Download as PDF


Subscribe to our news